RÉSUMÉ
Background: Brain metastasis is a common problem in patients with NSCLC. This study was done to study the risk factors associated with the development of brain metastasis and assess treatment response in NSCLC to improve patient survival. Methods: This was a retro-prospective study in which 126 patients with non-small cell lung carcinoma with brain metastasis were taken for the study. Results: The mean age in study group was 56.1±12.72 years. Adenocarcinoma was found in 57.1% and squamous cell carcinoma in 41.3% patients. 65.9% patients received chemotherapy for primary disease followed by targeted therapy in 34 (27.0%) patients. 53.9% patients received WBRT after diagnosis of brain metastasis and 23% WBRT and systemic chemotherapy while as14.3% received WBRT and targeted therapy and 2.4% received WBRT, systemic chemotherapy and targeted therapy, 1.6% patients received systemic chemotherapy, WBRT and local RT to the primary site and 0.8% each was treated with gamma knife therapy; surgery, WBRT and targeted therapy; SRS and WBRT. Median overall survival of patients with brain metastasis who received WBRT was 2.5 months and patients who received WBRT and systemic chemotherapy was 9.0 months while patients with brain metastasis who received WBRT and targeted therapy was 14.3 months. Conclusions: The median overall survival as per treatment received after diagnosis of brain metastasis was higher in patients who received WBRT and targeted therapy as compared to patients who received WBRT and systemic chemotherapy and patients who received WBRT only.
RÉSUMÉ
Background: Diabetes is one of the most common chronic conditions in the world. The worldwide prevalence of diabetes mellitus (DM) has risen dramatically over the past two decades because of increasing obesity and reduced activity levels. The purpose of this study was to show the association between depression and diabetes. Methods: It was a cross-study. The study included 240 patients who were chosen randomly with no gender bias. A convenient subject of 240 diabetic patients was interviewed. Results: Out of the total 240 diabetic patients, included in this study, the majority of patients, 52.63% in the age group of 60 years had depression with a Hamilton score of >19 while 47.37% of patients in the age of 40 to 50 years had Hamilton score of >19. 84.21% of males had depression with a Hamilton score >19 as compared to females who had a Hamilton score of 15.79%. The patients within the age group of 40-59 have 2.5 times more risk of having depression as compared to the age group of 20 to 39 and patients in the age group >60 years have 4.23 times higher risk of depression as compared to patients in the age group of 20 to 39 years. The association between gender and depression shows that males have a higher rate of depression (78.17%) as compared to females (21.81%) with an odd's ratio of 3.0. Conclusions: Our study showed a high prevalence of depression and anxiety in male patients and the elderly age group. Planning and implementation of screening for mental health issues in the elderly population diagnosed with a lifestyle disease-such as type 2 diabetes mellitus-with existing comorbidities should be recognized as one of the most important goals of the public health system. It seems necessary to involve medical teams in the screening process to verify the symptoms, promptly establish the diagnosis, and initiate the appropriate depression treatment. In diabetic patients, depression remains underdiagnosed and an important aspect of the diabetic specialists would be the awareness of this quite common co-morbidity.
RÉSUMÉ
Background: Breast cancer is the most common cancer among women and one of the most important causes of death among them. The present study tries to evaluate the demographic, clinical, and pathological profile of female breast cancer patients in Kashmir Methods: This study was done in government medical college Srinagar, department of radiation oncology. A retrospective review of 84 patients of breast cancer treated between January 2021 and March 2023 was done. Results: A total of 84 patients were taken for this study. Most patients presented in the 4th and 5th decade of life with a mean age of 45.5± 8.58. 50% of the patients were having T2 followed by 19.04% having T4 and 16.66% having T1 while 14.28 % had T3 stage. 32.1% of patients were having N0 nodal status, 25.0% were having N3 followed by 23.80% had N1 and 19.04% had N2 nodal disease.52.38% were having stage II and 36.90% were having stage III and 4.76% were having stage IV. 85.71% were having invasive ductal carcinoma, 9.52% were having invasive lobular carcinoma and 4.76% were having medullary carcinoma. 23.80% of patients were Triple +, 27.38 % of patients were Triple Negative, 25.0% were ER+/ PR+. Conclusions: The incidence of female breast cancer was more in the age group of 41–50 years. Stage II was more followed by Stage III. The most common histopathology type was invasive ductal carcinoma. Triple negativity was seen more in our patients.